Several gene fusions are well-characterized and play significant roles in different types of cancer. For example:
BCR-ABL in chronic myelogenous leukemia (CML) ETV6-RUNX1 in acute lymphoblastic leukemia (ALL) TMPRSS2-ERG in prostate cancer EML4-ALK in non-small cell lung cancer (NSCLC)